Erectile Dysfunction Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Erectile Dysfunction stocks.

Erectile Dysfunction Stocks Recent News

Date Stock Title
Nov 20 LLY Jim Cramer on Eli Lilly and Company (LLY): ‘I’m Kind Of Blown Away’
Nov 20 PFE CDC warns of an imminent spike in COVID, flu cases
Nov 20 LLY Eli Lilly in pact with Chinese biotech for novel weight loss therapy
Nov 20 PFE 5 Year-to-Date Laggards to Buy Amid Solid Near-Term Upside Potential
Nov 20 LLY More companies covering weight loss drugs for their employees
Nov 20 LLY Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
Nov 20 PFE Pfizer Appoints Cancer Research Head Chris Boshoff as New R&D Chief
Nov 20 LLY China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug
Nov 20 PFE Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
Nov 20 LLY Eli Lilly Option Trade Produces $1,125, If You Can Tolerate The Heavy Risk
Nov 20 PFE Pfizer names head of oncology as new R&D chief
Nov 20 PFE Pfizer Announces New Chief Scientific Officer and President, Research & Development
Nov 20 PFE Pfizer names oncology head Chris Boshoff as R&D chief
Nov 20 PFE Pfizer Names New R&D Chief
Nov 20 PFE Pfizer, under pressure to change, names oncology head as new R&D chief
Nov 20 PFE Is It Time to Sell Eli Lilly and Pfizer Stocks?
Nov 20 LLY Is It Time to Sell Eli Lilly and Pfizer Stocks?
Nov 20 LLY The Zacks Analyst Blog Highlights Eli Lilly, PepsiCo and Morgan Stanley
Nov 20 LLY Verge Genomics Announces Milestones in Collaboration with Lilly to Discover and Develop Novel Treatments for ALS
Nov 20 PFE European Commission Approves Pfizer’s HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors
Erectile Dysfunction

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
A physical cause can be identified in about 80% of cases. These include cardiovascular disease, diabetes mellitus, neurological problems such as following prostatectomy, hypogonadism, and drug side effects. Psychological impotence is where erection or penetration fails due to thoughts or feelings; this is somewhat less frequent, in the order of about 10% of cases. In psychological impotence, there is a strong response to placebo treatment.
Treatment involves addressing the underlying causes, lifestyle modifications, and addressing psychosocial issues. In many cases, a trial of pharmacological therapy with a PDE5 inhibitor, such as sildenafil, can be attempted. In some cases, treatment can involve inserting prostaglandin tablets into the urethra, injecting smooth muscle relaxants and vasodilators into the penis, a penile prosthesis, a penis pump, or vascular reconstructive surgery. It is the most common sexual problem in men.

Browse All Tags